Multifunctional Transmembrane Protein Ligands for Cell-Specific Targeting of Plasma Membrane-Derived Vesicles.

作者: Chi Zhao , David J. Busch , Connor P. Vershel , Jeanne C. Stachowiak

DOI: 10.1002/SMLL.201600493

关键词:

摘要: Liposomes and nanoparticles that bind selectively to cell-surface receptors can target specific populations of cells. However, chemical conjugation ligands these particles is difficult control, frequently limiting ligand uniformity complexity. In contrast, the surfaces living cells are decorated with highly uniform sophisticated transmembrane proteins. Toward harnessing cellular capabilities, here it demonstrated plasma membrane vesicles (PMVs) derived from donor display engineered protein precisely on basis receptor expression. These multifunctional targeting proteins incorporate (i) a ligand, (ii) an intrinsically disordered spacer make sterically accessible, (iii) fluorescent domain enables quantification density PMV surface. PMVs affinity for epidermal growth factor (EGFR) at increasing concentrations breast cancer express levels EGFR. Further, as example generality this approach, expressing single-domain antibody against green fluorescence (eGFP) eGFP-tagged selectivity ≈50:1. The results demonstrate versatility cell systems, suggesting diverse applications drug delivery tissue engineering.

参考文章(56)
Elena V. Batrakova, Myung Soo Kim, Using exosomes, naturally-equipped nanocarriers, for drug delivery. Journal of Controlled Release. ,vol. 219, pp. 396- 405 ,(2015) , 10.1016/J.JCONREL.2015.07.030
Patrick Chames, Marc Van Regenmortel, Etienne Weiss, Daniel Baty, Therapeutic antibodies: successes, limitations and hopes for the future. British Journal of Pharmacology. ,vol. 157, pp. 220- 233 ,(2009) , 10.1111/J.1476-5381.2009.00190.X
Christoph Mamot, Udo Greiser, Dmitri B Kirpotin, James D Marks, Keelung Hong, John W Park, Daryl C Drummond, Epidermal Growth Factor Receptor (EGFR)-targeted Immunoliposomes Mediate Specific and Efficient Drug Delivery to EGFR- and EGFRvIII-overexpressing Tumor Cells Cancer Research. ,vol. 63, pp. 3154- 3161 ,(2003)
P.B. Maercklein, B.J. Hoerl, M.A. Zschunke, R.E. Scott, R.G. Perkins, Plasma membrane vesiculation in 3T3 and SV3T3 cells. I. Morphological and biochemical characterization Journal of Cell Science. ,vol. 35, pp. 229- 243 ,(1979) , 10.1242/JCS.35.1.229
Susan M. van Dommelen, Pieter Vader, Samira Lakhal, S.A.A. Kooijmans, Wouter W. van Solinge, Matthew J.A. Wood, Raymond M. Schiffelers, Microvesicles and exosomes: Opportunities for cell-derived membrane vesicles in drug delivery Journal of Controlled Release. ,vol. 161, pp. 635- 644 ,(2012) , 10.1016/J.JCONREL.2011.11.021
Shuyi Chen, Xianrui Zhao, Jingyi Chen, Jin Chen, Larisa Kuznetsova, Stanislaus S. Wong, Iwao Ojima, Mechanism-Based Tumor-Targeting Drug Delivery System. Validation of Efficient Vitamin Receptor-Mediated Endocytosis and Drug Release Bioconjugate Chemistry. ,vol. 21, pp. 979- 987 ,(2010) , 10.1021/BC9005656
Richard J. Simpson, Søren S. Jensen, Justin W. E. Lim, Proteomic profiling of exosomes: Current perspectives Proteomics. ,vol. 8, pp. 4083- 4099 ,(2008) , 10.1002/PMIC.200800109
Guillaume T. Charras, Margaret Coughlin, Timothy J. Mitchison, L. Mahadevan, Life and Times of a Cellular Bleb Biophysical Journal. ,vol. 94, pp. 1836- 1853 ,(2008) , 10.1529/BIOPHYSJ.107.113605
Karl R. Schmitz, Atrish Bagchi, Rob C. Roovers, Paul M.P. van Bergen en Henegouwen, Kathryn M. Ferguson, Structural Evaluation of EGFR Inhibition Mechanisms for Nanobodies/VHH Domains. Structure. ,vol. 21, pp. 1214- 1224 ,(2013) , 10.1016/J.STR.2013.05.008